Chartwell Rx Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?
CHARTWELL RX has three hundred and eighty-two approved drugs.
There is one tentative approval on CHARTWELL RX drugs.
Drugs and US Patents for Chartwell Rx
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | VIGABATRIN | vigabatrin | FOR SOLUTION;ORAL | 211790-001 | Mar 10, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211963-001 | Feb 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075048-001 | Aug 22, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | MECLOFENAMATE SODIUM | meclofenamate sodium | CAPSULE;ORAL | 072263-001 | Nov 29, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | HALOPERIDOL | haloperidol | TABLET;ORAL | 071209-003 | Nov 17, 1986 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214217-001 | May 5, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Rx | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040196-006 | Sep 30, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell Rx
Similar Applicant Names
Here is a list of applicants with similar names.